SF-36 scales | Omeprazole (n = 23) | Placebo (n = 25) | ||
---|---|---|---|---|
At baseline | After 2 weeks | At baseline | After 2 weeks | |
Total average SF-36 score | 53.9 (46.6-61.2) | 63.3*# (56.2-70.4) | 50.0 (43.7-56.3) | 52.9* (45.3-60.6) |
Physical functioning | 63.5 (54.1-72.9) | 68.1 # (57.8-78.3) | 56.4 (49.2-63.6) | 61.6 (52.9-70.3) |
Limitations due to physical health problems | 34.8 (15.8-53.7) | 59.8# (39.5-80.1) | 35.0 (17.4-52.6) | 37.0 (20.7-53.4) |
Bodily pain | 50.5 (39.8-61.3) | 66.6*# (55.8-77.5) | 41.3 (32.8-49.8) | 49.4* (36.2-62.6) |
General health perception | 45.9 (37.4-54.3) | 50.4* (46.2-54.7) | 41.0 (34.5-47.5) | 43.0* (37.1-49.0) |
Physical health component (summarized) | 48.7 (38.9-58.4) | 61.2*# (52.4-74.4) | 43.4 (35.9-50.9) | 47.8* (47.3-66.2) |
Limitations due to personal and emotional problems | 65.2 (46.5-83.9) | 75.4 (60.2-90.6) | 60.0 (41.4-78.6) | 53.3 (34.7-72.0) |
Energy/fatigue (vitality) | 52.4 (44.7-60.1) | 57.6 (49.8-65.4) | 46.4 (40.3-52.5) | 52.6# (44.4-60.8) |
Emotional well-being | 52.7 (47.9-57.5) | 62.3# (54.8-69.8) | 53.9 (49.1-58.8) | 57.1 (49.4-64.9) |
Social functioning | 61.4 (49.8-73.1) | 71.2 (60.7-81.7) | 64.5 (62.4-76.6) | 64.0 (51.3-76.7) |
Mental health component (summarized) | 57.9 (50.0-65.9) | 66.6# (58.8-74.4) | 56.2 (48.6-63.8) | 56.8 (47.3-66.2) |